Mary L. McMaster
- Genetics top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Rheumatology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Co-authors
- Alisa M. GoldsteinDilys M. ParryNaoko IshibeChristina M. BromleyMargaret A. TuckerPorcia T. BradfordLynn R. GoldinOla Landgren
- Topics
- Chronic Lymphocytic Leukemia Research (30 papers)Lymphoma Diagnosis and Treatment (25 papers)Immunodeficiency and Autoimmune Disorders (15 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyThe EMBO Journal
- Partner nations
- United StatesSwedenUnited Kingdom
In The Last Decade
Mary L. McMaster
53 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Genetics 1.3k
- Pathology and Forensic Medicine 1.3k
- Rheumatology 935
- Pulmonary and Respiratory Medicine 843
- Oncology 827
Countries citing papers authored by Mary L. McMaster
This map shows the geographic impact of Mary L. McMaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary L. McMaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary L. McMaster more than expected).
Fields of papers citing papers by Mary L. McMaster
This network shows the impact of papers produced by Mary L. McMaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary L. McMaster. The network helps show where Mary L. McMaster may publish in the future.
Co-authorship network of co-authors of Mary L. McMaster
This figure shows the co-authorship network connecting the top 25 collaborators of Mary L. McMaster. A scholar is included among the top collaborators of Mary L. McMaster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary L. McMaster. Mary L. McMaster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 12 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 22 | |
| 7 | 33 | |
| 8 | 18 | |
| 9 | 22 | |
| 10 | 28 | |
| 11 | 24 | |
| 12 | 7 | |
| 13 | 34 | |
| 14 | 34 | |
| 15 | 191 | |
| 16 | 48 | |
| 17 | Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivorsbreakdown → | 560 |
| 18 | 150 | |
| 19 | 51 | |
| 20 | 30 |
About Mary L. McMaster
Mary L. McMaster is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 57 papers that have together received 4.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). The work is most often cited by research in Genetics (1.3k citations), Pathology and Forensic Medicine (1.3k citations) and Oral Surgery (484 citations). Mary L. McMaster has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Alisa M. Goldstein, Dilys M. Parry, Naoko Ishibe, Christina M. Bromley, Margaret A. Tucker, Porcia T. Bradford, Lynn R. Goldin, Ola Landgren, Steven P. Treon and Meletios Α. Dimopoulos. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.